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Abstract
Background Cognitive dysfunction and changes in body
composition share common pathophysiological pathways.
The aim of the present paper was to evaluate whether
changes in appendicular muscle mass (AMM) and fat mass
(FM) are associated factors with an increased risk of cogni-
tive dysfunction in community-dwelling older women.
Methods A nested case–control study was performed in 181
women aged 75 years and older from a subsample of the
Epidemiologie de l'Osteoporose participants from Toulouse.
Body composition parameters at inclusion and 7 years later
(assessed by dual energy X-ray absorptiometry), and the
presence of cognitive dysfunction (dementia and mild cog-
nitive impairment) at 7 years of follow-up, assured by two
memory experts based on best clinical practice and validated
criteria, were obtained. Multivariate logistic regression
models assessed the association of percent change in AMM
and FM with risk of cognitive dysfunction.
Results At 7 years of follow-up, 15 participants suffered from
dementia, 6 suffered frommild cognitive impairment, and 160
were cognitively normal. Neither body composition changes
nor gait speed was found to be statistically associated with
cognitive dysfunction after controlling for potential con-
founders. Only age, over 85 years, was associated with an
increased risk of subsequent cognitive impairment (odds ratio
3.10; 95 % confidence interval 1.07–8.87).
Conclusions No significant association could be evidenced
between changes in body composition and cognitive dys-
function. Due to the small sample size, statistical power
could be an issue. The study could also suggest the possibil-
ity that the risk of cognitive dysfunction is not mediated by
changes in body composition.
Keywords Body composition . Fat mass . Muscle mass .
Cognitive decline . Old age
1 Introduction
Although recent surveys evidenced a relationship between
changes over time in age-related body composition parame-
ters (i.e., fat mass or muscle mass), cognitive decline, and
brain atrophy, suggesting common underlying pathophysio-
logical mechanisms, supporting data to confirm this hypoth-
esis are still scarce and controversial [1–5].
Up to date, all surveys have presented data based on a
single body composition assessment, so that the dynamic
nature of muscle mass (MM) or fat mass (FM) has not been
taken into account. This single-assessment approach could
dampen the association between body composition and cog-
nitive dysfunction [6]. Indeed, changes in MM over time,
rather than a single-point assessment, could be associated
with cognitive decline as shown for other adverse clinical
events like onset of mobility disability [7]. In the line with
this hypothesis, changes in body mass index (BMI) over time
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are associated with cognitive decline, and the presence of
cognitive decline or dementia has reciprocally been associ-
ated with involuntary weight loss [8].
The hypothesis, of the present paper, is that the dynamic
nature of body composition (assessed by percentage change
in MM and FM over time) rather than a single assessment
might be related to subsequent risk of cognitive dysfunction
in community-dwelling older women. To this end, a nested
case–control study was performed in the Epidemiologie de
l'Osteoporose (EPIDOS) study.
2 Methods
2.1 EPIDOS cohort
Data are from the EPIDOS cohort, a French observational
prospective multicenter cohort study designed to evaluate
risk factors for hip fractures in community-dwelling women
aged 75 years and older. Details about the study have previ-
ously been published [9]. Briefly, between January 1992 and
January 1994, 7,598 women from five French cities
volunteered to participate in EPIDOS. Women unable to
walk independently (aids were allowed), with history of
femoral neck fracture or hip replacement, or were institu-
tionalized were excluded. Local ethics committee of the
participating centers approved the study, and each participant
provided informed consent. An additional study on dementia
risk factors in 1999–2000 was proposed to all the volunteers
from Toulouse. In this new investigation, data on cognitive
performances were collected during a standardized interview
by trained memory experts, and some of the participants also
volunteered for a new body composition assessment by dual
energy X-ray absorptiometry (DXA) [10, 11].
2.2 Study sample
From the participants of the EPIDOS Toulouse center
(n=1,492), a subsample with full cognitive assessment at
7 years of follow-up (n=714), also with a new DXA assess-
ment (n=181) were considered for the present analyses (Fig. 1).
2.3 Assessment of baseline covariates
Participants underwent standardized visits, including admin-
istration of structured questionnaires, clinical examination,
and assessment of physical performance. Visits were
conducted by trained nurses. Education was defined by a
dichotomous variable (i.e., graduate versus not). Self-
reported recreational activities (such as walking, gymnastics,
cycling, swimming, or gardening), their type, frequency, and
duration were also recorded. The variable “physically active”
was defined to approximately identify the fittest 20 % of the
study sample, which is equivalent at having practiced at least a
1-h activity or more per week over the past month [4, 6]. A
standardized assessment of gait speed was performed at base-
line. Participants were asked to perform a 6-m walk at their
usual pace. Walking aids were allowed. Testing began when
the command “start” was given by the assessor, and time (in
seconds) required to complete the task was recorded. The
faster of two walks was retained for the present analysis.
2.4 Assessment of body composition parameters
(baseline and at 7 years)
Body composition parameters were assessed at baseline
(1992–1994) using a DXA scanner (Lunar DPX-Plus, GE
Lunar Corp., Madison, WI) and a different scan at 7 years
(1999–2000) of follow-up (QDR 4500 W Hologic, Waltham,
MA). DXA measurements were performed by a trained tech-
nician, and the DXA machines were regularly calibrated. The
muscle mass index (MMI; appendicular lean mass, in kilo-
grams, relative to height squared) and the fat mass index
(FMI; total fat mass, relative to height squared) were obtained
for each participant during the two assessments [12]. As
height changes over time, square height was derived from
the height (in meters) measured at each assessments. The
change in the MMI and the FMI was obtained by a simple
subtraction, expressing the difference of each of the indexes as
a percent change of the baseline value. Although different
DXA machines were used, no adjustment of body composi-
tion values was performed as all participants underwent the
same study procedure and due to the fact that the magnitude of
linear calibration would identically affect the delta of body
composition of all participants. Cross-calibration of the two
DXA machines was performed in the year 2000 using the
body composition assessment (bone, muscle, and fat mass) of
seven healthy female volunteers. There were no statistical
differences in between the measurements when comparing
fat mass and lean mass, so that the data obtained of the two
DXA machines could be comparable [13].
2.5 Assessment of cognitive performances at 7 years
of follow-up
At the seventh year of follow-up, all cases of dementia were
recorded during a single structured and standardized home-
based interview. During this visit, cognitive performances
were assessed with the Mini-Mental State Examination [14],
the Grober and Buschke test [15], and the IADL test [16]. In
a double-blind manner, two memory specialists established
the diagnosis of dementia or mild cognitive impairment.
Clinical suspicion of dementia was diagnosed using the
Diagnostic and Statistical Manual of Mental Disorders, 4th
ed. criteria [17]. Mild cognitive impairment (MCI) was
based on the Peterson criteria [18].
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2.6 Statistical analyses
Data were analyzed with STATAv11.0 (Stata Corp., College
Station, TX). Variables were compared according to the
presence/absence of dementia using Student's t test or chi-
square statistics as appropriate. Multivariate logistic regres-
sion analyses assessed the association of change in the MMI
and the FMI with subsequent dementia risk. The models
were adjusted for age and gait speed, known risk factors
for dementia onset [4].
3 Results
The main baseline and follow-up characteristics of the study
participants according to their dementia status are presented in
Table 1. Of 181 women, 21 (11.6 %) suffered from cognitive
dysfunction (6 presented MCI and 15, dementia). A nonsig-
nificant difference was found for most of the studied variables
(i.e., education, physical activity, percent change in MMI and
FM) across cognitive dysfunction groups. Only age, gait
speed, and difference in BMI over time were found statisti-
cally significant. Participants with cognitive dysfunction at
7 years presented a significant lower MMSE score. All par-
ticipants had a score over 15, so that all cases of dementia
were at the mild and moderate stages of the disease.
Results of the adjusted regression models are presented in
Table 2. No statistical association could be evidenced between
cognitive dysfunction and percent change in body composi-
tion (expressed in tertiles, p for trend 0.18). Neither gait speed
nor change in BMI was associated with an increased risk of
cognitive dysfunction, suggesting that the results for percent
changes in body composition in the present study may be
underpowered. Only age, over 85 years, was associated with
an increased risk of cognitive dysfunction (odds ratio (OR)
3.10; 95 % confidence interval (CI) 1.07–8.87).
4 Discussion
In the present analyses, no association could be found be-
tween 7-year changes in body composition and cognitive
dysfunction. These results are consistent with previous
cross-sectional analysis based on sarcopenia definitions re-
lated to cognitive dysfunction [6]. And although common
underlying pathophysiological mechanisms have been hy-
pothesized, current data do not support the existence of a link
between changes in body composition and increased risk of
dementia. Another hypothesis suggested by the results of a
recent survey (and needing further inquiry) is that body
composition could be a prognostic factor for cognitive de-
cline at the dementia stage, with the possibility that changes
in body composition occur at later and more severe stages of
cognitive decline [5]. It is also possible, like for other critical
health outcomes, that performance but not changes in MM or
FM are associated with dementia [19, 20].
Finally, the main limit is that the study could be under-
powered as evidenced by a nonstatistical association be-
tween gait speed and cognitive dysfunction (contradictory
with the results performed in a larger EPIDOS population)
n = 714 (48.8%)
Full data on cognitive evaluation after 7 
years of follow-up* $
n = 748 (51.2%)
Not reassessed
Death: 193 (13.2%)
Withdrew: 141 (9.6%)
Lost to Follow-up: 414 (28.3%)
n = 181 (25.4%)
Accepted DXA assessment
Dementia: 15 (8.3%)
MCI: 6 (3.3%)
Normal: 160 (88.4%)
n = 533 (74.6%)
Refused DXA assessment
Dementia: 191 (35.8%)
MCI: 52 (9.8%)
Normal: 290 (54.4%)
n = 7575
EPIDOS 
n = 1462
EPIDOS-Toulouse
n = 6113
EPIDOS Amiens, Lyon, Montpellier, 
and Paris.
Fig. 1 Flow chart of study
population. MCI stands for mild
cognitive impairment; dementia
stands for all subtypes of
dementia (Alzheimer's disease,
vascular or mixed dementia,
Lewy corps dementia, fronto-
temporal dementia, Parkinson
dementia). The asterisk indicates
that the diagnosis of dementia
at 7 years was established after
a standardized home-based
assessment with cognitive
performances evaluated by the
Mini-Mental State Examination,
Grober and Buschke test, and
instrumental activities of daily
living tests. The dollar sign
indicates that the baseline
cognitive impairment was
assessed using the Short Portable
Mental Status Questionnaire
with a score of 8 or above as the
validated cutoff value for normal
cognitive functioning
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and by the large CI found for the variables [4]. Due to the
small study sample, dementia and MCI both were catego-
rized in cognitive dysfunction. This could dampen the asso-
ciation as a minority of MCI participants will eventually not
evolve to a dementia stage. The generalizability of the results
is also challenged by the restriction of the EPIDOS study to
only relatively healthy older women; therefore, our findings
might not be applicable to men, different settings, and other
health profiles. Even more, as shown in the flow chart, partic-
ipants suffering from dementia at 7 years of follow-up were
more likely to refuse a new DXA assessment than cognitively
intact participants. This issue could affect the possible associ-
ation in the EPIDOS study. Although the DXA assessments
were comparable during the cross-calibration performed dur-
ing the follow-up study at 7 years, the results need to be
interpreted with caution. The main limit is that no cross-
calibration could be performed at baseline. Software upgrades,
calibrations, and tube changes over the 7-year period could
render the baseline assessment not comparable. Although not
true for fat mass, and lean mass, the significant bone measure-
ment differences found in the cross-calibration could be
explained by these factors.
Table 2 Association of percent
change in muscle mass and fat
mass with cognitive dysfunction
OR odds ratio, CI confidence
interval,MMImuscle mass index
(in kilograms/squared height),
FMI fat mass index (in kilo-
grams/squared height), BMI
body mass index (in kilograms/
squared height)
Variables Adjusted model
OR (95 % CI)
p value
For OR For trend
Age (year) <80 Ref – –
≥80 3.10 (1.07–8.87) 0.04
Gait speed (m s−1) >0.8 Ref – –
≤0.8 2.21 (0.79–6.18) 0.13
7-year difference in BMI 0.80 (0.59–1.08) 0.14 –
Tertiles of percentage change in MMI (%) −37.3 to −9.1 2.08 (0.56–7.71) 0.27 0.18
−9.2 to −3.9 1.07 (0.27–4.20) 0.93
−3.8 to 19.4 Ref –
Tertiles of percentage change in FMI (%) −71.5 to −9.8 1.66 (0.34–8.23) 0.54 0.18
−9.5 to 3.6 2.72 (0.64–11.67) 0.18
3.8 to 144.5 Ref –
Table 1 Characteristics
according to the presence of
cognitive dysfunction (n=181)
MMI muscle mass index (in ki-
lograms/squared height), FMI fat
mass index (in kilograms/
squared height), MMSE Mini-
Mental State Examination (score
over 30). Italics represent a sta-
tistical significant difference
a Age, body mass index (in kilo-
grams/squared height), certifi-
cate of graduation, physically ac-
tive, and gait speed are baseline
characteristics
b Results are presented as num-
ber (percentage) or mean ± stan-
dard deviation
c Based on Student's or chi-
square statistics or nonparamet-
ric tests as appropriate
Variablesa No cognitive
dysfunctionb
(n=160)
Cognitive
dysfunctionb
(n=21)
p valuec
Age 77.8±2.2 79.1±2.2 0.01
Age (year) <80 126 (78.7) 11 (52.4) <0.01
≥80 34 (21.3) 10 (47.6)
Body mass index 24.2±3.3 24.2±2.9 0.99
Body mass index at 7 years 24.3±3.6 22.8±3.6 0.07
MMSE scores at 7 years 28.4±1.4 22.5±3.3 <0.01
Certificate of graduation Graduate 146 (91.2) 18 (85.7) 0.41
Less than
graduate
14 (8.8) 3 (14.3)
Physically active Yes 57 (35.8) 6 (28.6) 0.51
No 102 (64.2) 15 (71.4)
Gait speed (m s−1) >0.8 121 (75.6) 11 (52.4) 0.02
≤0.8 39 (24.4) 10 (47.6)
Tertiles of percent change in the MMI (%) −37.3 to −9.1 51 (83.6) 10 (16.4) 0.34
−9.2 to −3.9 54 (90.0) 6 (10.0)
−3.8 to 19.4 55 (91.7) 5 (8.3)
Tertiles of percent change in the FMI (%) −71.5 to −9.8 51 (83.6) 10 (16.4) 0.34
−9.5 to 3.6 54 (90.0) 6 (10.0)
3.8 to 144.5 55 (91.7) 5 (8.3)
Difference in body mass index 0.2±1.7 −1.0±2.2 <0.01
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5 Conclusions
In this cohort of community-dwelling independent older wom-
en, percent change in body composition parameters was not
found to be associated with cognitive dysfunction. Differently,
age was confirmed to be associated with cognitive decline. The
analyses suggest that the study might be underpowered, or that
no association exists between changes in body composition and
cognitive dysfunction. Further studies on the topic are needed
to confirm these findings, including larger samples including
moreDXA assessments over time or participants with cognitive
dysfunction at a later dementia stage.
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